PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT 2.1 Preface 2.2 Preface 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE Market ecosystem Market characteristics Market segmentation analysis PART 04: MARKET SIZING Market definition Market sizing 2018 Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition PART 06: MARKET SEGMENTATION BY PRODUCT Market segmentation by product Comparison by product Mitral valve restoration systems - Market size and forecast 2018-2023 Left ventricular restoration systems - Market size and forecast 2018-2023 Market opportunity by product PART 07: MARKET SEGMENTATION BY END-USER Market segmentation by end-user Comparison by end-user Hospitals - Market size and forecast 2018-2023 ASCs - Market size and forecast 2018-2023 Others - Market size and forecast 2018-2023 Market opportunity by end-user PART 08: CUSTOMER LANDSCAPE PART 09: GEOGRAPHIC LANDSCAPE Geographic segmentation Geographic comparison North America - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 Asia - Market size and forecast 2018-2023 ROW - Market size and forecast 2018-2023 Key leading countries Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES Market drivers Market challenges PART 12: MARKET TRENDS Development of mitral valve restoration systems with tissue engineering approach High R&D investments and M&A activities Growing awareness about cardiac restoration systems PART 13: VENDOR LANDSCAPE Overview Landscape disruption PART 14: VENDOR ANALYSIS Vendors covered Vendor classification Market positioning of vendors Abbott BioVentrix Inc. CryoLife Inc. Edwards Lifesciences Corp. NeoChord Inc. Xeltis AG PART 15: APPENDIX Research methodology List of abbreviations Definition of market positioning of vendors PART 16: EXPLORE TECHNAVIO   Exhibit 01: Global medical devices market Exhibit 02: Segments of global medical devices market Exhibit 03: Market characteristics Exhibit 04: Market characteristics analysis Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Five forces analysis 2018 Exhibit 11: Five forces analysis 2023 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2018 Exhibit 18: Product - Market share 2018-2023 (%) Exhibit 19: Comparison by product Exhibit 20: Mitral valve restoration systems - Market size and forecast 2018-2023 ($ millions) Exhibit 21: Mitral valve restoration systems - Year-over-year growth 2019-2023 (%) Exhibit 22: Left ventricular restoration systems - Market size and forecast 2018-2023 ($ millions) Exhibit 23: Left ventricular restoration systems - Year-over-year growth 2019-2023 (%) Exhibit 24: Market opportunity by product Exhibit 25: End-user - Market share 2018-2023 (%) Exhibit 26: Comparison by end-user Exhibit 27: Hospitals - Market size and forecast 2018-2023 ($ millions) Exhibit 28: Hospitals - Year-over-year growth 2019-2023 (%) Exhibit 29: ASCs - Market size and forecast 2018-2023 ($ millions) Exhibit 30: ASCs - Year-over-year growth 2019-2023 (%) Exhibit 31: Others - Market size and forecast 2018-2023 ($ millions) Exhibit 32: Others - Year-over-year growth 2019-2023 (%) Exhibit 33: Market opportunity by end-user Exhibit 34: Customer landscape Exhibit 35: Customer landscape analysis Exhibit 36: Market share by geography 2018-2023 (%) Exhibit 37: Geographic comparison Exhibit 38: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 39: North America - Year-over-year growth 2019-2023 (%) Exhibit 40: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 41: Europe - Year-over-year growth 2019-2023 (%) Exhibit 42: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 43: Asia - Year-over-year growth 2019-2023 (%) Exhibit 44: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 45: ROW - Year-over-year growth 2019-2023 (%) Exhibit 46: Key leading countries Exhibit 47: Market opportunity Exhibit 48: Impact of drivers and challenges Exhibit 49: Vendor landscape Exhibit 50: Landscape disruption Exhibit 51: Vendor landscape analysis Exhibit 52: Vendors covered Exhibit 53: Vendor classification Exhibit 54: Market positioning of vendors Exhibit 55: Abbott - Vendor overview Exhibit 56: Abbott - Business segments Exhibit 57: Abbott - Organizational developments Exhibit 58: Abbott - Geographic focus Exhibit 59: Abbott - Segment focus Exhibit 60: Abbott - Key offerings Exhibit 61: BioVentrix Inc. - Vendor overview Exhibit 62: BioVentrix Inc. - Business segments Exhibit 63: BioVentrix Inc. - Key offerings Exhibit 64: CryoLife Inc. - Vendor overview Exhibit 65: CryoLife Inc. - Product segments Exhibit 66: CryoLife Inc. - Organizational developments Exhibit 67: CryoLife Inc. - Geographic focus Exhibit 68: CryoLife Inc. - Segment focus Exhibit 69: CryoLife Inc. - Key offerings Exhibit 70: Edwards Lifesciences Corp. - Vendor overview Exhibit 71: Edwards Lifesciences Corp. - Product segments Exhibit 72: Edwards Lifesciences Corp. - Organizational developments Exhibit 73: Edwards Lifesciences Corp. - Geographic focus Exhibit 74: Edwards Lifesciences Corp. - Segment focus Exhibit 75: Edwards Lifesciences Corp. - Key offerings Exhibit 76: NeoChord Inc. - Vendor overview Exhibit 77: NeoChord Inc. - Business segments Exhibit 78: NeoChord Inc. - Key offerings Exhibit 79: Xeltis AG - Vendor overview Exhibit 80: Xeltis AG - Business segments Exhibit 81: Xeltis AG - Key offerings Exhibit 82: Validation techniques employed for market sizing Exhibit 83: Definition of market positioning of vendors

Abbott BioVentrix Inc. CryoLife Inc. Edwards Lifesciences Corp. NeoChord Inc. Xeltis AG